To identify genes influencing age at onset (AAO) in two common neurodegenerative diseases, a genomic screen was performed for AAO in families with Alzheimer disease (AD; n=449) and Parkinson disease (PD; n=174). Heritabilities between 40%–60% were found in both the AD and PD data sets. For PD, significant evidence for linkage to AAO was found on chromosome 1p (LOD = 3.41). For AD, the AAO effect of APOE (LOD = 3.28) was confirmed. In addition, evidence for AAO linkage on chromosomes 6 and 10 was identified independently in both the AD and PD data sets. Subsequent unified analyses of these regions identified a single peak on chromosome 10q between D10S1239 and D10S1237, with a maximum LOD score of 2.62. These data suggest that a common gene ...
We performed an affected sib-pair (ASP) linkage analysis to test for the effects of age at onset (AA...
Alzheimer disease (AD) is a complex disorder characterized by a wide range, within and between famil...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with high prevalence, which impo...
To identify genes influencing age at onset (AAO) in two common neurodegenerative diseases, a genomic...
We previously reported a linkage region on chromosome 1p (LOD = 3.41) for genes controlling age at o...
Patients with Alzheimer's disease (AD) often have a family history of the disease, implicating genet...
OBJECTIVES: Copy number variants (CNVs) have been recognized as a source of genetic variation that c...
BACKGROUND: Age at onset in Parkinson disease (PD) is a highly heritable quantitative trait for whic...
Parkinson’s disease (PD) is the most common cause of neurodegenerative movement disorder and the sec...
The identification of novel genetic variants contributing to the widespread in the age of onset (AOO...
Apolipoprotein E (APOE) is the only confirmed susceptibility gene for late-onset Alzheimer disease (...
Three decades of genetic research in Alzheimer disease (AD) have substantially broadened our underst...
The aim of the study was to identify chromosomal regions that may harbor putative genetic variants i...
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) pr...
Although mutations in the amyloid-β precursor protein (APP) gene are known to confer high risk of Al...
We performed an affected sib-pair (ASP) linkage analysis to test for the effects of age at onset (AA...
Alzheimer disease (AD) is a complex disorder characterized by a wide range, within and between famil...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with high prevalence, which impo...
To identify genes influencing age at onset (AAO) in two common neurodegenerative diseases, a genomic...
We previously reported a linkage region on chromosome 1p (LOD = 3.41) for genes controlling age at o...
Patients with Alzheimer's disease (AD) often have a family history of the disease, implicating genet...
OBJECTIVES: Copy number variants (CNVs) have been recognized as a source of genetic variation that c...
BACKGROUND: Age at onset in Parkinson disease (PD) is a highly heritable quantitative trait for whic...
Parkinson’s disease (PD) is the most common cause of neurodegenerative movement disorder and the sec...
The identification of novel genetic variants contributing to the widespread in the age of onset (AOO...
Apolipoprotein E (APOE) is the only confirmed susceptibility gene for late-onset Alzheimer disease (...
Three decades of genetic research in Alzheimer disease (AD) have substantially broadened our underst...
The aim of the study was to identify chromosomal regions that may harbor putative genetic variants i...
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) pr...
Although mutations in the amyloid-β precursor protein (APP) gene are known to confer high risk of Al...
We performed an affected sib-pair (ASP) linkage analysis to test for the effects of age at onset (AA...
Alzheimer disease (AD) is a complex disorder characterized by a wide range, within and between famil...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with high prevalence, which impo...